Q: Artificial intelligence (AI) techniques have sent vast waves across healthcare, even fueling an active discussion of whether AI doctors will eventually replace human physicians in the future. Do you believe that human physicians will be replaced by machines in the foreseeable future? What are...
Q: Artificial intelligence (AI) techniques have sent vast waves across healthcare, even fueling an active discussion of whether AI doctors will eventually replace human physicians in the future. Do you believe that human physicians will be replaced by machines in the foreseeable future? What are...
Q: What need is Insitro addressing? A: Despite the marvels and triumphs of modern medicine many diseases remain untreatable. And the development of novel therapeutics to address these conditions isn’t getting any easier or cheaper, with clinical trial success rates hovering in the single-digits and the...
Q: Checkpoint inhibitors, particularly with PD-L1/PD-1 targeting agents, have benefited a broad range of patients with cancer. How will we improve on this? A: It’s true that PD-L1/PD-1 inhibitors have led to durable responses in a subset of patients, and survival benefit in many of the...
Q: What makes the Maccabi Research Institute biobank unique? A: To explain the uniqueness of the Maccabi Biobank (named "Tipa" in Hebrew which means “drop” or “just a little”), first you must know a little about Maccabi. ...
Q: What need is Karius addressing? A: Physicians often have difficulty pinpointing the exact pathogen that is causing disease. Conventional diagnostics like blood cultures or PCR can have poor sensitivity due to pretreatment with antibiotics, the breadth of potential pathogens present, and the requirement for...
Q: What need is HL7 addressing? A: For more than three decades, HL7 has provided the platform to enable global health data interoperability. This is more important than ever, as the cost of healthcare has increased exponentially, and the complexity of clinical evidence has...
Q: What need is Invitae addressing? A: Our mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae is uniquely positioned to answer some of life’s most serious and complex questions with the highest...
Q: What need is Immunomic Therapeutics, Inc. addressing? A: Immunomic Therapeutics’ nucleic acid vaccines have the potential to utilize the body’s natural biochemistry to develop a broad immune response, including antibody production, cytokine release and critical immunological memory....
Q: What are some of the critical contributions that academic institutions and medical centers are making to implement and accelerate precision medicine? A: Over the past decade, the field of precision medicine has created technologies enabling far more personalized and effective health care delivery. Many of...
